Association/NN
Analysis/NN
of/IN
Reactive/JJ
Oxygen/NN
Species-Hypertension/NN
Genes/NNS
Discovered/JJ
by/IN
Literature/JJ
Mining/NN
./.
====================
Oxidative/JJ
stress/NN
,/,
which/WDT
results/VBZ
in/IN
an/DT
excessive/JJ
product/NN
of/IN
reactive/JJ
oxygen/NN
species/NNS
(/(
ROS/NN
)/)
,/,
is/VBZ
one/CD
of/IN
the/DT
fundamental/JJ
mechanisms/NNS
of/IN
the/DT
development/NN
of/IN
hypertension/NN
./.
====================
In/IN
the/DT
vascular/JJ
system/NN
,/,
ROS/NN
have/VBP
physical/JJ
and/CC
pathophysiological/JJ
roles/NNS
in/IN
vascular/JJ
remodeling/NN
and/CC
endothelial/JJ
dysfunction/NN
./.
====================
In/IN
this/DT
study/NN
,/,
ROS-hypertension-related/JJ
genes/NNS
were/VBD
collected/VBN
by/IN
the/DT
biological/JJ
literature-mining/JJ
tools/NNS
,/,
such/JJ
as/IN
SciMiner/JJ
and/CC
gene2pubmed/VBD
,/,
in/IN
order/NN
to/TO
identify/VB
the/DT
genes/NNS
that/WDT
would/MD
cause/VB
hypertension/NN
through/IN
ROS/NN
./.
====================
Further/RB
,/,
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
located/JJ
within/IN
these/DT
gene/NN
regions/NNS
were/VBD
examined/VBN
statistically/RB
for/IN
their/PRP$
association/NN
with/IN
hypertension/NN
in/IN
6,419/CD
Korean/JJ
individuals/NNS
,/,
and/CC
pathway/NN
enrichment/JJ
analysis/NN
using/VBG
the/DT
associated/VBN
genes/NNS
was/VBD
performed/VBN
./.
====================
The/DT
2,945/CD
SNPs/NNS
of/IN
237/CD
ROS-hypertension/NN
genes/NNS
were/VBD
analyzed/VBN
,/,
and/CC
68/CD
genes/NNS
were/VBD
significantly/RB
associated/VBN
with/IN
hypertension/NN
(/(
p/NN
</JJR
0.05/CD
)/)
./.
====================
The/DT
most/JJS
significant/JJ
SNP/NN
was/VBD
rs2889611/NN
within/IN
MAPK8/NN
(/(
p/NN
=/JJ
2.70/CD
×/CD
10-5/CD
;/:
odds/NNS
ratio/NN
,/,
0.82/CD
;/:
confidence/RB
interval/JJ
,/,
0.75/CD
to/TO
0.90/CD
)/)
./.
====================
This/DT
study/NN
demonstrates/VBZ
that/IN
a/DT
text/JJ
mining/JJ
approach/NN
combined/VBN
with/IN
association/NN
analysis/NN
may/MD
be/VB
useful/JJ
to/TO
identify/VB
the/DT
candidate/NN
genes/NNS
that/WDT
cause/VBP
hypertension/NN
through/IN
ROS/NN
or/CC
oxidative/JJ
stress/NN
./.
====================
Hypertension/NN
is/VBZ
defined/VBN
as/IN
blood/NN
pressure/NN
measurement/NN
consistently/RB
higher/JJR
than/IN
140/CD
mm/NN
Hg/NN
systolic/JJ
blood/NN
pressure/NN
(/(
SBP/NN
)/)
and/or/CC
90/CD
mm/NN
Hg/NN
diastolic/JJ
blood/NN
pressure/NN
(/(
DBP/NN
)/)
[/(
1/CD
]/)
./.
====================
It/PRP
is/VBZ
a/DT
complex/NN
syndrome/NN
determined/VBN
by/IN
genetic/JJ
and/CC
environmental/JJ
factors/NNS
and/CC
affected/VBD
by/IN
multiple/JJ
genetic/JJ
factors/NNS
to/TO
30/CD
%/NN
to/TO
50/CD
%/NN
of/IN
blood/NN
pressure/NN
variability/NN
in/IN
human/JJ
hypertension/NN
[/(
2/CD
]/)
./.
====================
Although/IN
hypertension/NN
is/VBZ
a/DT
leading/VBG
cause/VBP
of/IN
cardiovascular/JJ
disease/NN
,/,
ischemic/JJ
heart/NN
disease/NN
,/,
and/CC
stroke/JJ
,/,
the/DT
exact/JJ
cause/VBP
of/IN
hypertension/NN
is/VBZ
unclear/JJ
[/(
3/CD
]/)
./.
====================
Oxidative/JJ
stress/NN
,/,
which/WDT
results/VBZ
in/IN
an/DT
excessive/JJ
product/NN
of/IN
reactive/JJ
oxygen/NN
species/NNS
(/(
ROS/NN
)/)
,/,
is/VBZ
one/CD
of/IN
the/DT
fundamental/JJ
mechanisms/NNS
of/IN
the/DT
development/NN
of/IN
hypertension/NN
./.
====================
In/IN
the/DT
vascular/JJ
system/NN
,/,
ROS/NN
has/VBZ
physical/JJ
and/CC
pathophysiological/JJ
roles/NNS
that/WDT
are/VBP
important/JJ
in/IN
vascular/JJ
remodeling/NN
and/CC
endothelial/JJ
dysfunction/NN
associated/VBN
with/IN
hypertension/NN
[/(
4/CD
]/)
./.
====================
Since/IN
1960/CD
,/,
when/WRB
the/DT
association/NN
between/IN
free/JJ
radicals/NNS
and/CC
hypertension/NN
was/VBD
reported/VBN
[/(
5/CD
]/)
,/,
plenty/NN
of/IN
data/NNS
supporting/VBG
a/DT
role/NN
of/IN
oxidative/JJ
stress/NN
in/IN
hypertension/NN
have/VBP
been/VBN
published/VBN
./.
====================
However/RB
,/,
the/DT
evidence/NN
of/IN
whether/IN
oxidative/JJ
stress/NN
causes/VBZ
hypertension/NN
is/VBZ
weak/JJ
,/,
and/CC
a/DT
few/JJ
clinical/JJ
studies/NNS
have/VBP
shown/VBN
the/DT
relationship/NN
between/IN
blood/NN
pressure/NN
and/CC
ROS/NN
./.
====================
Nonetheless/RB
,/,
oxidative/JJ
stress/NN
has/VBZ
an/DT
important/JJ
role/NN
in/IN
vascular/JJ
biology/NN
and/CC
a/DT
potential/JJ
role/NN
in/IN
hypertension/NN
./.
====================
In/IN
this/DT
study/NN
,/,
ROS-hypertension-related/JJ
genes/NNS
were/VBD
collected/VBN
by/IN
the/DT
biological/JJ
literature-mining/JJ
tools/NNS
,/,
such/JJ
as/IN
SciMiner/JJ
and/CC
gene2pubmed/VBD
,/,
in/IN
order/NN
to/TO
identify/VB
the/DT
genes/NNS
that/WDT
would/MD
cause/VB
hypertension/NN
through/IN
ROS/NN
./.
====================
Further/RB
,/,
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
located/JJ
within/IN
these/DT
gene/NN
regions/NNS
were/VBD
examined/VBN
statistically/RB
for/IN
their/PRP$
association/NN
with/IN
hypertension/NN
in/IN
6,419/CD
Korean/JJ
individuals/NNS
,/,
and/CC
pathway/NN
enrichment/JJ
analysis/NN
using/VBG
the/DT
associated/VBN
genes/NNS
was/VBD
performed/VBN
./.
====================
Study/NN
participants/NNS
and/CC
genotyping/VBG
====================
The/DT
Korea/NN
Association/NN
Resource/NN
(/(
KARE/NN
)/)
study/RB
recruited/VBD
10,038/CD
participants/NNS
aged/JJ
40/CD
years/NNS
to/TO
69/CD
years/NNS
from/IN
the/DT
rural/JJ
Ansung/JJ
and/CC
urban/JJ
Ansan/DT
cohorts/NNS
and/CC
has/VBZ
been/VBN
previously/RB
described/VBN
in/IN
detail/NN
[/(
6/CD
]/)
;/:
1,196/CD
subjects/NNS
were/VBD
excluded/VBN
due/IN
to/TO
poor/JJ
genotyping/VBG
data/NNS
,/,
and/CC
we/PRP
also/RB
excluded/VBN
subjects/NNS
with/IN
prehypertensive/JJ
status/NN
(/(
120/CD
mm/NN
Hg/JJ
</JJR
SBP/NN
</JJR
140/CD
mm/NN
Hg/JJ
and/or/CC
80/CD
mm/NN
Hg/JJ
</JJR
DBP/NN
</JJR
90/CD
mm/NN
Hg/JJ
)/)
./.
====================
In/IN
total/JJ
,/,
6,420/CD
participants-1,968/NN
hypertensive/JJ
cases/NNS
with/IN
hypertensive/JJ
therapy/NN
or/CC
SBP/NN
≥/CD
140/CD
mm/NN
Hg/NN
or/CC
DBP/NN
≥/CD
90/CD
mm/NN
Hg/NN
and/CC
4,452/CD
controls/NNS
with/IN
SBP/NN
≤/CD
120/CD
mm/NN
Hg/NN
and/CC
DBP/NN
≤/CD
80/CD
mm/NN
Hg-were/NNP
examined/VBN
for/IN
a/DT
hypertension/NN
case/NN
control/NN
study/NN
./.
====================
The/DT
Affymetrix/JJ
Genome-Wide/NN
Human/JJ
SNP/NN
array/NN
5.0/CD
(/(
Affymetrix/JJ
,/,
Inc./NNP
,/,
Santa/NN
Clara/NN
,/,
CA/NNP
,/,
USA/NN
)/)
was/VBD
used/VBN
to/TO
genotype/NN
KARE/NN
study/NN
individuals/NNS
./.
====================
The/DT
accuracy/NN
of/IN
the/DT
genotyping/VBG
was/VBD
examined/VBN
by/IN
Bayesian/JJ
Robust/NNP
Linear/JJ
Modeling/JJ
using/VBG
the/DT
Mahalanobis/NN
distance/NN
(/(
BRLMM/NN
)/)
genotyping/VBG
algorithm/NN
[/(
7/CD
]/)
./.
====================
The/DT
sample/JJ
and/CC
SNP/NN
quality/NN
control/NN
criteria/NNS
have/VBP
been/VBN
described/VBN
[/(
6/CD
]/)
./.
====================
In/IN
brief/JJ
,/,
samples/NNS
with/IN
accuracies/NNS
that/DT
were/VBD
lower/JJR
than/IN
98/CD
%/NN
,/,
high/JJ
missing/VBG
genotype/NN
call/JJ
rates/NNS
(/(
≥4/CD
%/NN
)/)
,/,
high/JJ
heterozygosity/NN
(/(
>/JJR
30/CD
%/NN
)/)
,/,
or/CC
gender/JJR
biases/NNS
were/VBD
excluded/VBN
./.
====================
SNPs/NNS
were/VBD
excluded/VBN
according/VBG
to/TO
filter/RBR
criteria/NNS
as/IN
follows/VBZ
:/:
SNP/NN
call/JJ
rate/NN
>/JJR
5/CD
%/NN
,/,
minor/JJ
allele/NN
frequency/NN
</JJR
0.01/CD
,/,
and/CC
Hardy-Weinberg/JJ
equilibrium/NN
p/NN
</JJR
1/CD
×/NN
10-6/CD
./.
====================
After/IN
quality/NN
control/NN
,/,
8,842/CD
individuals/NNS
and/CC
352,228/CD
markers/NNS
remained/VBD
./.
====================
Ascertaining/VBG
ROS-/NN
and/CC
hypertension-related/JJ
genes/NNS
====================
The/DT
SciMiner/NN
[/(
8/CD
]/)
web-based/VBD
literature/NN
mining/VBG
tool/NN
was/VBD
used/VBN
to/TO
obtain/VB
gene/NN
sets/NNS
associated/VBN
with/IN
ROS/NN
and/CC
hypertension/NN
./.
====================
SciMiner/NNP
was/VBD
run/JJ
on/IN
a/DT
query/RB
of/IN
``/NN
Reactive/JJ
Oxygen/NN
Species/NNS
''/CD
[/(
MeSH/NN
]/)
AND/CC
``/CD
Hypertension/NN
''/CD
[/(
MeSH/NN
]/)
,/,
identifying/VBG
ROS-hypertension/NN
articles/NNS
and/CC
genes/NNS
as/IN
of/IN
April/NN
24/CD
,/,
2012/CD
./.
====================
We/PRP
also/RB
retrieved/VBD
genes/NNS
for/IN
these/DT
ROS-hypertension/NN
articles/NNS
from/IN
NCBI/NN
gene2pubmed/VBN
(/(
ftp/JJ
:/:
//ftp.ncbi.nlm.nih.gov/gene/DATA/NN
)/)
data/NNS
./.
====================
The/DT
newly/RB
found/VBN
genes/NNS
from/IN
gene2pubmed/VBN
were/VBD
added/VBN
to/TO
the/DT
ROS-hypertension/NN
gene/NN
set/NN
./.
====================
The/DT
positions/NNS
of/IN
genes/NNS
in/IN
the/DT
human/JJ
genome/NN
were/VBD
downloaded/VBN
from/IN
the/DT
Ensembl/NN
Biomart/NN
database/NN
(/(
NCBI/NN
build/JJ
36/CD
)/)
./.
====================
Some/DT
gene/NN
symbols/NNS
were/VBD
different/JJ
from/IN
the/DT
results/NNS
of/IN
SciMiner/NN
and/CC
Biomart/NN
,/,
such/JJ
as/IN
NOS2A/NN
→/CD
NOS2/NN
and/CC
STN/NN
→/CD
EEF1A2/NN
./.
====================
The/DT
functional/JJ
analysis/NN
tools/NNS
,/,
such/JJ
as/IN
SciMiner/JJ
,/,
WebGestalt/NN
[/(
9/CD
,/,
10/CD
]/)
,/,
and/CC
DAVID/NN
[/(
11/CD
,/,
12/CD
]/)
,/,
were/VBD
used/VBN
for/IN
enrichment/JJ
analysis/NN
to/TO
find/VB
the/DT
pathway/NN
with/IN
ROS-hypertension-associated/JJ
genes/NNS
,/,
and/CC
the/DT
statistical/JJ
significance/NN
of/IN
biological/JJ
functions/NNS
was/VBD
calculated/VBN
with/IN
Benjamini/NNP
and/CC
Hochberg-adjusted/JJ
p/NN
</JJR
0.05/CD
as/IN
the/DT
cutoff/JJ
./.
====================
Statistical/JJ
analyses/NNS
====================
PLINK/NN
version/NN
v1.07/RB
(/(
http/NN
:/:
//pngu.mgh.harvard.edu/~purcell/plink/NN
)/)
was/VBD
used/VBN
to/TO
perform/VB
the/DT
association/NN
analysis/NN
,/,
and/CC
the/DT
hypertension/NN
case/NN
control/NN
study/NN
was/VBD
tested/VBN
by/IN
logistic/JJ
regression/NN
analysis/NN
./.
====================
The/DT
association/NN
tests/NNS
were/VBD
based/VBN
on/IN
an/DT
additive/JJ
genetic/JJ
model/NN
and/CC
adjusted/VBN
for/IN
recruitment/NN
area/NN
,/,
age/NN
,/,
sex/NN
,/,
and/CC
body/NN
mass/NN
index/NN
./.
====================
Ascertaining/VBG
ROS/NN
and/CC
hypertension/NN
candidate/NN
genes/NNS
====================
With/IN
the/DT
results/NNS
of/IN
SciMiner/NNP
,/,
queried/VBD
with/IN
``/JJ
'Reactive/JJ
Oxygen/NN
Species/NNS
'/``
[/(
MeSH/NN
]/)
AND/CC
'Hypertension/NN
'/``
[/(
MeSH/NN
]/)
''/RB
,/,
574/CD
genes/NNS
were/VBD
obtained/VBN
from/IN
903/CD
ROS-hypertension-related/JJ
articles/NNS
;/:
49/CD
genes/NNS
were/VBD
found/VBN
through/IN
the/DT
NCBI/NN
gene2pubmed/VBN
data/NNS
with/IN
these/DT
903/CD
papers/NNS
,/,
and/CC
only/RB
2/CD
genes/NNS
out/IN
of/IN
49/CD
genes/NNS
were/VBD
new/JJ
to/TO
the/DT
574/CD
SciMiner/NNP
genes/NNS
./.
====================
Three/CD
hundred/VBN
seventeen/CD
genes/NNS
(/(
55/CD
%/NN
)/)
among/IN
the/DT
576/CD
ROS-hypertension/NN
genes/NNS
were/VBD
referenced/VBN
in/IN
only/RB
1/CD
article/NN
(/(
Table/JJ
1/CD
)/)
and/CC
were/VBD
excluded/VBN
for/IN
further/JJ
analysis/NN
,/,
with/IN
259/CD
genes/NNS
remaining/VBG
./.
====================
Using/VBG
Ensembl/JJ
Biomart/NN
(/(
NCBI/NN
Build/JJ
36/CD
)/)
,/,
we/PRP
then/RB
extracted/VBN
the/DT
position/NN
information/NN
of/IN
259/CD
genes/NNS
,/,
and/CC
the/DT
genes/NNS
located/JJ
on/IN
chromosomes/NNS
X/NN
,/,
Y/NN
,/,
and/CC
MT/NN
were/VBD
also/RB
excluded/VBN
./.
====================
Finally/RB
,/,
237/CD
genes/NNS
that/WDT
included/VBD
SNPs/NNS
genotype/NN
information/NN
from/IN
KARE/NN
data/NNS
within/IN
the/DT
gene/NN
boundary/NN
(/(
±20/CD
kb/NN
upstream/RB
and/CC
downstream/JJ
of/IN
the/DT
gene/NN
)/)
were/VBD
selected/VBN
,/,
and/CC
2,945/CD
SNPs/NNS
were/VBD
tested/VBN
for/IN
hypertension/NN
association/NN
analysis/NN
./.
====================
The/DT
frequently/RB
mentioned/VBN
genes/NNS
(/(
number/NN
of/IN
papers/NNS
>/JJR
40/CD
)/)
in/IN
the/DT
ROS-hypertension/NN
papers/NNS
are/VBP
shown/VBN
in/IN
Table/JJ
2/CD
./.
====================
Association/NN
analysis/NN
of/IN
hypertension/NN
====================
We/PRP
examined/VBD
2,945/CD
SNPs/NNS
of/IN
237/CD
genes/NNS
for/IN
a/DT
hypertension/NN
case/NN
control/NN
study/NN
by/IN
logistic/JJ
regression/NN
analysis/NN
;/:
68/CD
genes/NNS
were/VBD
significantly/RB
associated/VBN
with/IN
hypertension/NN
(/(
p/NN
</JJR
0.05/CD
)/)
(/(
Table/JJ
3/CD
)/)
./.
====================
The/DT
most/JJS
significant/JJ
SNP/NN
was/VBD
rs2889611/RB
within/IN
mitogen-activated/JJ
protein/NN
kinase/NN
8/CD
(/(
MAPK8/NNS
;/:
p/NN
=/JJ
2.70/CD
×/RB
10-5/CD
;/:
odds/NNS
ratio/NN
[/(
OR/NN
]/)
,/,
0.82/CD
;/:
confidence/RB
interval/JJ
[/(
CI/NN
]/)
,/,
0.75/CD
to/TO
0.90/CD
)/)
,/,
and/CC
rs1356415/RB
from/IN
PROM1/NN
and/CC
rs4536994/RB
from/IN
KDR/NN
were/VBD
strongly/RB
associated/VBN
with/IN
hypertension/NN
(/(
p/NN
=/JJ
3.45/CD
×/RB
10-4/CD
;/:
OR/NNP
,/,
1.18/CD
;/:
CI/NNP
,/,
1.08/CD
to/TO
1.29/CD
and/CC
p/NN
=/JJ
3.73/CD
×/RB
10-4/CD
;/:
OR/NNP
,/,
1.19/CD
;/:
CI/NNP
,/,
1.08/CD
to/TO
1.31/CD
,/,
respectively/RB
)/)
./.
====================
Functional/JJ
analysis/NN
of/IN
ROS-hypertension/NN
gene/NN
set/NN
====================
The/DT
68/CD
targets/NNS
that/WDT
were/VBD
significantly/RB
associated/VBN
with/IN
ROS/NN
and/CC
hypertension/NN
were/VBD
tested/VBN
for/IN
functional/JJ
enrichment/JJ
analysis/NN
./.
====================
Three/CD
functional/JJ
analysis/NN
tools/NNS
,/,
SciMiner/NNP
,/,
Web-Gestalt/NN
,/,
and/CC
DAVID/NN
,/,
identified/VBD
34/CD
significantly/RB
over-represented/VBN
biological/JJ
functions/NNS
in/IN
the/DT
Kyoto/NN
Encyclopedia/NN
of/IN
Genes/NNS
and/CC
Genomes/NNS
pathway/NN
[/(
13/CD
,/,
14/CD
]/)
./.
====================
The/DT
most/JJS
significant/JJ
biological/JJ
pathway/NN
from/IN
the/DT
3/CD
functional/JJ
analysis/NN
tools/NNS
was/VBD
focal/JJ
adhesion/NN
,/,
involved/VBN
in/IN
the/DT
cell/NN
communication/NN
pathway/NN
group/NN
(/(
Table/JJ
4/CD
)/)
./.
====================
The/DT
most/JJS
frequent/JJ
pathway/NN
group/NN
was/VBD
cancer/NN
pathways/NNS
(/(
n/NN
=/JJ
9/CD
)/)
,/,
such/JJ
as/IN
glioma/NN
and/CC
pancreatic/JJ
cancer/NN
./.
====================
Eight/CD
other/JJ
pathways/NNS
related/JJ
to/TO
signal/VB
transduction/NN
and/CC
11/CD
organismal/JJ
system/NN
pathways/NNS
(/(
level/NN
1/CD
)/)
related/JJ
to/TO
the/DT
immune/JJ
system/NN
,/,
endocrine/JJ
system/NN
,/,
and/CC
nervous/JJ
system/NN
were/VBD
significantly/RB
identified/VBN
./.
====================
Oxidative/JJ
stress/NN
due/JJ
to/TO
excess/VB
production/NN
of/IN
ROS/NN
is/VBZ
one/CD
of/IN
the/DT
reasons/NNS
for/IN
the/DT
development/NN
of/IN
hypertension/NN
[/(
4/CD
]/)
./.
====================
To/TO
identify/VB
genetic/JJ
risk/NN
factors/NNS
that/WDT
induce/VBP
hypertension/NN
through/IN
ROS/NN
,/,
this/DT
study/NN
extracted/VBD
ROS-hypertension-related/JJ
genes/NNS
using/VBG
text-mining/VBG
tools/NNS
and/CC
investigated/VBD
the/DT
association/NN
of/IN
genes/NNS
with/IN
hypertension/NN
in/IN
6,419/CD
unrelated/JJ
Koreans/NNS
./.
====================
MAPK8/NNS
,/,
PROM1/NN
,/,
and/CC
KDR/NN
had/VBD
strong/JJ
association/NN
signals/NNS
with/IN
hypertension/NN
(/(
p/NN
</JJR
4/CD
×/CD
10-4/CD
)/)
./.
====================
Especially/RB
,/,
MAPK8/NN
was/VBD
published/VBN
13/CD
times/NNS
in/IN
ROS-hypertension/NN
articles/NNS
,/,
while/IN
most/JJS
genes/NNS
strongly/RB
associated/VBN
with/IN
hypertension/NN
(/(
p/NN
</JJR
0.01/CD
)/)
were/VBD
published/VBN
an/DT
average/NN
of/IN
6.29/CD
times/NNS
./.
====================
MAPK8/NNS
,/,
known/VBN
as/IN
JNK1/NN
,/,
included/VBD
19/CD
SNPs/NNS
in/IN
the/DT
KARE/NN
genotype/JJ
data/NNS
,/,
and/CC
14/CD
SNPs/NNS
among/IN
the/DT
19/CD
SNPs/NNS
were/VBD
significantly/RB
associated/VBN
with/IN
hypertension/NN
,/,
ranging/VBG
in/IN
p-value/JJ
from/IN
2.7/CD
×/NNP
10-5/CD
to/TO
1.3/CD
×/NNP
10-3-moderate/JJ
in/IN
comparison/NN
with/IN
a/DT
genome-wide/JJ
association/NN
study/RB
(/(
GWAS/NNP
)/)
-significant/JJ
p-value/JJ
(/(
5.0/CD
×/NNP
10-8/CD
)/)
;/:
thus/RB
MAPK8/NNS
was/VBD
not/RB
considered/VBN
as/IN
the/DT
candidate/NN
gene/NN
of/IN
hypertension/NN
in/IN
previous/JJ
GWAS/NNP
studies/NNS
[/(
15/CD
,/,
16/CD
]/)
./.
====================
MAPK8/NNS
plays/VBZ
a/DT
key/JJ
role/NN
in/IN
T/NN
cell/NN
proliferation/NN
,/,
apoptosis/NN
,/,
and/CC
differentiation/NN
through/IN
the/DT
studies/NNS
of/IN
Jnk1-deficient/JJ
mice/NNS
[/(
17/CD
,/,
18/CD
]/)
./.
====================
MAPK8/NNS
was/VBD
included/VBN
on/IN
HumanCVD/NN
Beadchip/NN
,/,
a/DT
customized/JJ
cardiovascular/JJ
disease/NN
(/(
CVD/NN
)/)
SNP/NN
chip/NN
containing/VBG
more/RBR
than/IN
2,100/CD
CVD/NN
candidate/NN
genes/NNS
[/(
19/CD
]/)
./.
====================
However/RB
,/,
previous/JJ
cardiovascular/JJ
disease/NN
GWASs/NNS
regarding/VBG
high-density/JJ
lipoprotein/NN
particle/NN
features/NNS
,/,
lipids/NNS
,/,
and/CC
apolipoproteins/NNS
did/VBD
not/RB
report/VB
the/DT
association/NN
of/IN
the/DT
MAPK8/NN
gene/NN
[/(
20/CD
,/,
21/CD
]/)
./.
====================
Therefore/RB
,/,
it/PRP
needs/VBZ
replication/NN
to/TO
make/VB
it/PRP
sure/VBP
whether/IN
MAPK8/NN
is/VBZ
indeed/RB
involved/VBN
in/IN
the/DT
development/NN
of/IN
hypertension/NN
through/IN
ROS/NN
./.
====================
Using/VBG
the/DT
text-mining/JJ
tool/NN
,/,
we/PRP
found/VBD
237/CD
ROS-hypertension-related/JJ
genes/NNS
./.
====================
The/DT
most/JJS
frequent/JJ
gene/NN
was/VBD
AGT/NN
(/(
angiotensinogen/NN
[/(
serpin/NN
peptidase/NN
inhibitor/NN
,/,
clade/NN
A/DT
,/,
member/NN
8/CD
]/)
)/)
,/,
which/WDT
was/VBD
reported/VBN
on/IN
320/CD
ROS-hypertension/NN
articles/NNS
,/,
but/CC
it/PRP
was/VBD
not/RB
associated/VBN
with/IN
hypertension/NN
in/IN
this/DT
study/NN
or/CC
our/PRP$
previous/JJ
report/NN
[/(
22/CD
]/)
./.
====================
Most/JJS
of/IN
the/DT
genes/NNS
that/WDT
were/VBD
published/VBN
in/IN
more/RBR
than/IN
40/CD
articles/NNS
were/VBD
not/RB
associated/VBN
with/IN
hypertension/NN
or/CC
showed/VBD
weak/JJ
associations/NNS
;/:
6/CD
of/IN
17/CD
genes/NNS
were/VBD
significant/JJ
,/,
and/CC
the/DT
lowest/JJS
p-value/JJ
was/VBD
0.014/CD
(/(
nitric/JJ
oxide/NN
synthase/NN
1/CD
[/(
neuronal/JJ
]/)
,/,
NOS1/NN
)/)
./.
====================
The/DT
average/JJ
number/NN
of/IN
articles/NNS
for/IN
genes/NNS
with/IN
strong/JJ
signals/NNS
(/(
p/NN
</JJR
0.01/CD
)/)
was/VBD
6.29/CD
articles/NNS
,/,
and/CC
that/IN
for/IN
those/DT
with/IN
moderate/JJ
signals/NNS
(/(
0.01/CD
≤/CD
p/NN
</JJR
0.05/CD
)/)
was/VBD
18.90/CD
articles/NNS
./.
====================
Two/CD
large/JJ
GWASs/NNS
,/,
the/DT
International/JJ
Consortium/NN
for/IN
Blood/NN
Pressure/NN
Genome-Wide/NN
Association/NN
Studies/NNS
(/(
IC-BPGWAS/NN
)/)
[/(
23/CD
]/)
and/CC
Asian/JJ
Genetic/JJ
Epidemiology/NN
Network/NN
Blood/NN
Pressure/NN
(/(
AGEN-BP/NN
)/)
[/(
16/CD
]/)
,/,
reported/VBD
33/CD
blood/NN
pressure/NN
candidate/NN
loci/NNS
in/IN
2011/CD
./.
====================
Among/IN
66/CD
genes/NNS
within/IN
the/DT
33/CD
blood/NN
pressure/NN
candidate/NN
loci/NNS
,/,
6/CD
genes/NNS
were/VBD
included/VBN
in/IN
the/DT
ROS-hypertension/NN
gene/NN
set/NN
as/IN
follows/VBZ
:/:
NPPA/NN
,/,
NPPB/NN
,/,
PTPN11/NN
,/,
CYP1A1/NN
,/,
GNAS/NN
,/,
and/CC
EDN3/NN
./.
====================
We/PRP
examined/VBD
their/PRP$
association/NN
with/IN
hypertension/NN
by/IN
case/NN
control/NN
study/NN
,/,
and/CC
NPPA/NN
,/,
NPPB/NN
,/,
and/CC
CYP1A1/NN
were/VBD
associated/VBN
with/IN
hypertension/NN
with/IN
p/NN
</JJR
0.05/CD
./.
====================
The/DT
weakly/RB
associated/VBN
SNP/NN
rs1023252/NN
(/(
p/NN
=/JJ
0.047/CD
)/)
overlapped/VBD
with/IN
NPPA/NN
and/CC
NPPB/NN
,/,
and/CC
rs2472299/NN
within/IN
the/DT
CYP1A1/NN
locus/NN
was/VBD
previously/RB
mentioned/JJ
for/IN
the/DT
oxidative/JJ
stress/NN
pathway/NN
from/IN
WikiPathway/NN
(/(
http/NN
:/:
//www.wikipathways.org/JJ
)/)
./.
====================
In/IN
conclusion/NN
,/,
we/PRP
listed/VBD
ROS-hypertension/NN
genes/NNS
that/WDT
were/VBD
extracted/VBN
by/IN
a/DT
text-mining/JJ
approach/NN
and/CC
tested/VBN
their/PRP$
association/NN
with/IN
hypertension/NN
in/IN
Korean/JJ
population/NN
./.
====================
Several/JJ
genes/NNS
,/,
including/VBG
the/DT
MAPK8/NN
gene/NN
,/,
were/VBD
identified/VBN
as/IN
potential/JJ
genes/NNS
causing/VBG
hypertension/NN
through/IN
ROS/NN
./.
====================
This/DT
study/NN
demonstrates/VBZ
that/IN
a/DT
text-mining/JJ
approach/NN
combined/VBN
with/IN
association/NN
analysis/NN
may/MD
be/VB
useful/JJ
to/TO
identify/VB
candidate/NN
genes/NNS
that/WDT
cause/VBP
hypertension/NN
through/IN
ROS/NN
or/CC
oxidative/JJ
stress/NN
./.
====================
Distribution/NN
of/IN
number/NN
of/IN
genes/NNS
according/VBG
to/TO
number/NN
of/IN
papers/NNS
====================
Frequent/JJ
reactive/JJ
oxygen/NN
species/NNS
(/(
ROS/NN
)/)
-hypertension/NN
genes/NNS
(/(
number/NN
of/IN
papers/NNS
>/JJR
40/CD
)/)
====================
Associated/VBN
genes/NNS
of/IN
hypertension/NN
(/(
p/NN
</JJR
0.01/CD
)/)
====================
Top/RB
10/CD
most/JJS
significant/JJ
pathways/NNS
through/IN
pathway/NN
enrichment/JJ
analysis/NN
with/IN
68/CD
genes/NNS
====================
